Board of Directors

Belief in a Mission...The PhRMA Foundation is lastingly indebted to a cadre of PhRMA Board members who despite uncommon demands on their time through the nature of their jobs have given more than three decades of faithful and sagacious service.  

They have done so, plainly, because they believed in what the Foundation was doing, and they believed in its potential for even greater performance in an essential mission.

John M. Leonard, M.D.

John M. Leonard, M.D.
(Chairman)
Vice President of Global Scientific and Medical Affairs
Abbott Laboratories
Abbott Park, IL
Garry A. Neil, M.D.

Garry A. Neil, M.D.
Vice Chairman & Treasurer
Corporate Vice President, Corporate Office of Science & Technology
Johnson & Johnson
Raritan, NJ
Dr. Thomas P. Koestler, Ph.D.

Thomas P. Koestler, Ph.D.
Executive Vice President, and President, Schering-Plough Research Institute
Schering Plough Corporation
Kenilworth, NJ
Martin Mackay, Ph.D.

Martin Mackay, Ph.D.
President, Pfizer Global Research and Development
Pfizer Inc.
New London, Connecticut
Steven M. Paul, M.D.

Steven M. Paul, M.D.
Executive Vice President, Science and Technology
President, Lilly Research Laboratories
Eli Lilly and Company
Indianapolis, IN
G. Mikael Dolsten, M.D., Ph.D.

G. Mikael Dolsten, M.D., Ph.D.
President, Research and Development
Senior Vice President, Wyeth
Wyeth Pharmaceuticals
Moncef Slaoui, Ph.D.

Moncef Slaoui, Ph.D.
Chairman, Research & Development
GlaxoSmithKline
King of Prussia, PA
Billy Tauzin

Billy Tauzin
President and Chief Executive Officer
PhRMA
Washington, DC